Alkion Bioinnovations
French tech company | Builders Republic
About
Biotech industrializing the plant-based production of vaccine adjuvants — growing the cells that yield saponins normally extracted from tree bark in automated bioreactors, securing a scalable, sustainable supply of the immune-boosting compounds used in modern and mRNA vaccines.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2017
- City
- BOULOGNE-BILLANCOURT
- Region
- IDF
- Tracked rounds
- 1
- Amount raised
- 4.4 M€ raised since 2020
Funding rounds
- Seed — 2025